One plaintiff’s lawsuit in Louisiana federal court over allegations that diabetes drug Actos increases the risk of bladder cancer resulted in a $9 billion verdict. What might a jury do in a case consolidating claims by two plaintiffs?
Takeda Pharmaceuticals America Inc. is at trial over combined claims by Delores Cipriano and Bertha Triana, who allege they received inadequate warnings about Actos. Cipriano’s attorney, Robert Eglet, said he plans to seek a multibillion-dollar verdict, the Las Vegas Review Journal reported.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
